Dr. Steven K. Bergstrom MD
Hematologist (Pediatric) | Pediatric Hematology-Oncology
280 W Macarthur Blvd Oakland CA, 94611Rating
5/5
About
Dr. Steven Bergstrom is a pediatric hematologist practicing in Oakland, CA. Dr. Bergstrom specializes in treating children that have a blood disease or cancer. Such blood diseases include disorders of red blood cells, white blood cells and/or platelets. The types of cancers that Dr. Bergstrom treats include leukemias, lymphomas and certain tumors. Dr. Bergstrom can also treat bleeding disorders in children. Pediatric hematologists can be found in childrens hospitals, community hospitals, university medical centers and more.
Board Certification
PediatricsAmerican Board of PediatricsABP- Pediatric Hematology-Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Capnocytophaga bacteremia in a patient with Hodgkin's disease following bone marrow transplantation: case report and review.
- SUP-HD1: a new Hodgkin's disease-derived cell line with lymphoid features produces interferon-gamma.
- Does a residents' continuity clinic provide primary care?
- Long-term follow-up of a patient transplanted for Hunter's disease type IIB: a case report and literature review.
- Treatment of chronic neutropenia with chloramphenicol.
- Pregnancy during therapy for childhood acute lymphoblastic leukemia: two case reports and a review of the literature.
- Arsenic trioxide in the treatment of a patient with multiply recurrent, ATRA-resistant promyelocytic leukemia: a case report.
Clinical Trials
- Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
- Study of Kidney Tumors in Younger Patients
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
- Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
- Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
- Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
- Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
- Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
- Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
- Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
- Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
- Selumetinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
- Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB or Stage IIIB-IVB Hodgkin Lymphoma
- Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
- PI3K/mTOR Inhibitor LY3023414 in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
- Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Dr. Steven K. Bergstrom MD's Practice location
Practice At 280 W Macarthur Blvd
280 W Macarthur Blvd -Oakland, CA 94611Get Direction
Dr. Steven K. Bergstrom MD's reviews
Write ReviewPatient Experience with Dr. Bergstrom
Recommended Articles
![]()
Why am I so Sleepy During the Daytime?Not sleeping enough can have serious consequences. Similarly, excessive sleepiness, especially in the morning, is not considered normal or healthy for anybody. Sleepiness is becoming a common problem in the country, with more than 20% of people suffering from it. When sleep affects the daily routine...
![]()
Overcoming Lymphoma: A South Philly Student's StoryIn April of 2018, 18-year-old Alexis Carine was diagnosed with Hodgkin’s lymphoma (HL), a blood cancer that begins in the lymphatic system. Her diagnosis was stage II HL, a cancer found in two or more lymph node areas, and both are either above or below the diaphragm (the muscle located just...
![]()
How Is Leukemia Diagnosed?Leukemia in its early stages may present no signs or symptoms, as these only appear when the leukemia cells have taken over a large number of normal blood cells. A person with leukemia is very lucky indeed if early-stage detection occurs incidentally, through a routine blood test or one done for...
![]()
PurpuraPurpuraPurpura refers to purple-colored spots that are usually seen on the skin, including mucous membranes and other organs. It is also called skin hemorrhages or blood spots.Purpura is usually recognized when there is pooling of blood under the skin due to ruptured small blood vessels. The size of...
![]()
Potential Causes of LeukopeniaIntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...
![]()
Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant RecipientsLymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...
Nearby Providers
![]()
Dr. Mignon L. Loh M.D.505 Parnassus Ave San Francisco CA 94143![]()
Dr. Debbie C. sakaguchi Sakai M.D.2979 20th Ave San Francisco CA 94132![]()
Dr. Theodore Paul Nicolaides Other505 Parnassus Ave San Francisco CA 94143![]()
Dr. William Clay Gustafson MD/PHD505 Parnassus Ave # M647 San Francisco CA 94143![]()
Dr. Alison T Matsunaga MD747 52nd Street Oakland CA 94609![]()
Mark Walters MO747 52nd Street Oakland CA 94609
Nearest Hospitals
KAISER FOUNDATION HOSPITAL - OAKLAND/RICHMONDl
275 W MACARTHUR BOULEVARD OAKLAND CA 94611ALTA BATES SUMMIT MEDICAL CENTERl
350 HAWTHORNE AVENUE OAKLAND CA 94609CHILDREN'S HOSPITAL & RESEARCH CENTER OAKLANDl
747 52ND STREET OAKLAND CA 94609